Trials / Completed
CompletedNCT02154919
Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction
Conservative Pharmacotherapy Versus Staged Percutaneous Coronary Intervention on Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 306 (actual)
- Sponsor
- Beijing Shijitan Hospital, Capital Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To compare the different effect of conservative pharmacotherapy and Staged Percutaneous Coronary Intervention (SPCI) on significant non-culprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) at presentation remains controversial
Conditions
- Conservative Pharmacotherapy
- Staged Percutaneous Coronary Intervention
- Non-culprit Vessels
- ST-Segment Elevation Myocardial Infarction
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous coronary intervention |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2013-12-01
- First posted
- 2014-06-03
- Last updated
- 2014-06-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02154919. Inclusion in this directory is not an endorsement.